| Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess CA Chappell, HC Wiesenfeld Clinical obstetrics and gynecology 55 (4), 893-903, 2012 | 203 | 2012 |
| Hepatitis C virus screening among children exposed during pregnancy CA Chappell, SL Hillier, D Crowe, LA Meyn, DL Bogen, EE Krans Pediatrics 141 (6), 2018 | 125 | 2018 |
| Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study CA Chappell, KK Scarsi, BJ Kirby, V Suri, A Gaggar, DL Bogen, IS Macio, ... The Lancet Microbe 1 (5), e200-e208, 2020 | 118 | 2020 |
| The effects of hormones and vaginal microflora on the glycome of the female genital tract: cervical-vaginal fluid BJ Moncla, CA Chappell, BM Debo, LA Meyn PloS one 11 (7), e0158687, 2016 | 80 | 2016 |
| The effects of reproductive hormones on the physical properties of cervicovaginal fluid CA Chappell, LC Rohan, BJ Moncla, L Wang, LA Meyn, K Bunge, ... American journal of obstetrics and gynecology 211 (3), 226. e1-226. e7, 2014 | 71 | 2014 |
| Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV KK Scarsi, KM Darin, CA Chappell, SM Nitz, M Lamorde Drug safety 39 (11), 1053-1072, 2016 | 59 | 2016 |
| Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy CA Chappell, M Lamorde, S Nakalema, BA Chen, H Mackline, SA Riddler, ... AIDS 31 (14), 1965-1972, 2017 | 46 | 2017 |
| A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus CA Chappell, EE Krans, K Bunge, I Macio, D Bogen, KK Scarsi, LA Meyn, ... Conference on Retroviruses and Opportunistic Infections, 4-7, 2019 | 42 | 2019 |
| Elevated risk of bacterial vaginosis among users of the copper intrauterine device: a prospective longitudinal cohort study K Peebles, FM Kiweewa, T Palanee-Phillips, C Chappell, D Singh, ... Clinical Infectious Diseases 73 (3), 513-520, 2021 | 40 | 2021 |
| Impact of bacterial vaginosis, as assessed by nugent criteria and hormonal status on glycosidases and lectin binding in cervicovaginal lavage samples BJ Moncla, CA Chappell, LK Mahal, BM Debo, LA Meyn, SL Hillier PLoS One 10 (5), e0127091, 2015 | 39 | 2015 |
| The effect of menopause on the innate antiviral activity of cervicovaginal lavage CA Chappell, CE Isaacs, W Xu, LA Meyn, K Uranker, CS Dezzutti, ... American journal of obstetrics and gynecology 213 (2), 204. e1-204. e6, 2015 | 37 | 2015 |
| Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity L Wang, S Koppolu, C Chappell, BJ Moncla, SL Hillier, LK Mahal PLoS One 10 (5), e0127021, 2015 | 26 | 2015 |
| Prevention of perinatal transmission of human immunodeficiency virus CA Chappell, SE Cohn Infectious Disease Clinics 28 (4), 529-547, 2014 | 23 | 2014 |
| Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART M Neary, CA Chappell, KK Scarsi, S Nakalema, J Matovu, SL Achilles, ... Journal of Antimicrobial Chemotherapy 74 (10), 3003-3010, 2019 | 21 | 2019 |
| Brief report: dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception JE Balkus, T Palanee-Phillips, K Reddy, S Siva, I Harkoo, C Nakabiito, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (2), e47-e51, 2017 | 18 | 2017 |
| Postpartum follow-up care for pregnant persons with opioid use disorder and hepatitis C virus infection M Jarlenski, Q Chen, KA Ahrens, L Allen, AE Austin, C Chappell, ... Obstetrics & Gynecology 139 (5), 916-918, 2022 | 16 | 2022 |
| Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial CM Boraas, SL Achilles, ML Cremer, CA Chappell, SE Lim, BA Chen Contraception 94 (5), 467-472, 2016 | 16 | 2016 |
| Experiences and perspectives from women taking investigational therapy for hepatitis C virus during pregnancy Y Kislovskiy, C Chappell, E Flaherty, ME Hamm, FA Cameron, EE Krans, ... Substance Abuse: Research and Treatment 15, 11782218211046261, 2021 | 13 | 2021 |
| Testing for hepatitis C in pregnancy: the time has come for routine rather than risk-based T Kushner, CA Chappell, AY Kim Current hepatology reports 18, 206-215, 2019 | 13 | 2019 |
| DELIVER: a safety study of a dapivirine vaginal ring and oral PrEP for the prevention of HIV during pregnancy K Bunge, JE Balkus, L Fairlie, AJ Mayo, C Nakabiito, N Mgodi, L Gadama, ... JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097, 2022 | 12 | 2022 |
